NTHL1 and breast cancer: The genotype data suggested a low increased risk of BC for heterozygous NTHL1 c.244C>T carriers in the additive model (odds ratio (OR) = 1.39 [95% confidence interval (CI) 1.18–1.64], P = 7.8 × 10–5) (Tables 2, 3).